NFKB1 and infection: These findings provide new pharmacological insight into the negative regulation of NF-κB-mediated inflammation in innate immune responses, highlighting Teuvincenone F as a potential new anti-inflammatory drug for the treatment of infection-related inflammatory and autoimmune diseases.